Sertraline NDC 68788-8669

Product information

Brand name (proprietary)

Sertraline

Generic name (nonproprietary)

sertraline

Active ingredients

Sertraline hydrochloride — 100 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Preferred Pharmaceuticals Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 077670

Marketing start

May 20, 2024

Listing expires

Dec 31, 2027

Other FDA classes

Cytochrome P450 2D6 Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)

Identifiers

Product ID 68788-8669_562f7d5b-44ac-4564-a713-221f3584d7c5SPL ID 562f7d5b-44ac-4564-a713-221f3584d7c5

Pharmacologic class

Serotonin Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468788866901 followed by a unit qualifier and the quantity Copy

Package 68788-8669-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 077670

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 39.